20.500.12556/DiRROS-29727 Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration Network Objective: Women with psoriatic arthritis (PsA) may have reduced tumor necrosis factor inhibitor (TNFi) effectiveness compared to men. We examined sex differences in treatment response and retention rates during 24 months of follow-up among patients with PsA initiating their first TNFi. Methods: Data from PsA patients across 13 EuroSpA registries starting their first TNFi were pooled. Logistic regression was used to analyze the association between sex and treatment response, using low disease activity (LDA) according to DAS28-CRP ( sex differences tumor necrosis psoriatic arthritis EuroSpA razlike med spoloma tumorska nekroza psoriatični artritis EuroSpA true false true Angleški jezik Slovenski jezik Neznano 2026-06-03 15:28:44 2026-06-03 15:28:44 2026-06-04 04:04:46 0000-00-00 00:00:00 2024 0 0 str. 587-598 iss. 4, [article no.] 42758 Vol. 76 2024 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-002 2326-5191 10.1002/art.42758 173547267 RAZ_Hellamand_Pasoon_2024.pdf RAZ_Hellamand_Pasoon_2024.pdf 1 E09271570D3C30400CD447F56106F090 cd42a6d864b4330cfbdf0fdb2bffd3c26fbddff63f3cbf334375569407056585 5dfb99ec-5f50-11f1-9215-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=44668 https://acrjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/art.42758 1 2537e351-5f50-11f1-9215-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=44667 Univerzitetni klinični center Ljubljana 0 0 0